This week, in his radio programme “On va vers le beau“, Jonas Schneiter meets people who are working for sustainable solutions by developing different projects related to the production and transformation of hemp in Switzerland. Whether it is in the production of CBD, medicines, fashion or construction, he questions the role, the possibilities and the importance of hemp in an ecological transition process. Today, it is Cédric Heeb, founder and director of PhytoXtract SA and Christophe-Georges Christophi, head pharmacist of the Florissant Pharmacy. These are two members of the network, the Pharmacy “Florissant” and the Manufacturer “PhytoXtract SA”, who took part in this radio programme in the facilities of cannaxtract labs.
Bern, 08.03.2021 – The Council of States adopts the amendment to the Swiss Law on Narcotic Drugs and Psychotropic Substances. Access to medical cannabis will be made easier, as an exceptional authorisation from the FOPH for its use will no longer be required.
Bern, December 9th 2020. There is two good news for those who use #cannabis to relieve chronic pain and muscle spasms.
Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.
On February 1st 2022, the Swiss Association of Cantonal Chemists, announced in a press release that, in Switzerland, the vast majority of products sold containing the cannabis extract cannabidiol (CBD) do not meet legal requirements. It was relayed across many media channels, such as swissinfo stating that Most CBD cannabis products fail to meet standards. However, these findings do not apply to the medical/therapeutic cannabis.
The SRF documentary on Medical Cannabis provides an overview on the current market situation Key takeouts: good results on patients using the medicine high prices for patient due to 1 company dominant position flowers are not yet available as medicine (it will only be available with the #pilotprojects medical Cannabis still need to evolve from…
Visit the new educational event Cannabis as medicine – «From plant to patient». Implementation: 01.05.2021 – 30.06.2021 (on demand until 31.12.2021) Type: e-learning + online workshop (05.06.2021) Costs: CHF 350 Accreditations (among others): FPH: 100, accredited for continuing education FPH Offizin (role 1.2) and continuing education. SDV: requested SGAIM: 4 points for workshop + up…